Dti-mri findings in synthetic cannabinoid users.

Creative Commons License

Gökharman F., Aydin S., Paltun S., Fatihoğlu E., Yalçin Ş., Koşar P.

Turkish journal of medical sciences, cilt.50, ss.1022-1027, 2020 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 50
  • Basım Tarihi: 2020
  • Doi Numarası: 10.3906/sag-1905-5
  • Dergi Adı: Turkish journal of medical sciences
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.1022-1027
  • Anahtar Kelimeler: Bonzai, synthetic cannabinoids, white matter, diffusion tensor imaging, WHITE-MATTER ABNORMALITIES, EARLY-ONSET SCHIZOPHRENIA, MARIJUANA USE, PHARMACOLOGY
  • Erzincan Binali Yıldırım Üniversitesi Adresli: Evet

Özet

Background/aim: Synthetic cannabinoids (SCs) are full agonists of both cannabinoid receptors. Conventional magnetic resonance imaging (MRI) findings of SC users are mainly defined as diffusion restriction and T2/FLAIR hyperintensity. Diffusion tensor imaging (DTI) studies examining SC users have shown contradictory results. The aim of this study was to define white matter (WM) changes of SC users using DTI.